{"name":"Alphyn Biologics","slug":"alphyn-biologics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"zabalafin","genericName":"zabalafin","slug":"zabalafin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"zabalafin","genericName":"zabalafin","slug":"zabalafin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPVnZGYTBfR3o4czAtRFJXU1dwX190aXBvd3dCVUhxUnZXekRSeDR1TmN4ZkpHZWhVSlVBcWNVNXlXYmVQamUzWm9UR0hfY0pkaDNzV0NPdGV1aXFDREEzTGZTOUk0aEppbk9GUGs5b3R6MGdOOHR4djRLTkh2OW1Ub2t0dGh6SUV5VEctOFpOTzRHb05OSmRSVUQzRjhOOEZpZ3hfQ1hONzk0dm9xeEZqeTczSFBoWjllakRONGEzRzI1RDAxMlF6NmM3b0JYajJBWG1oU3dPczFZTkt6a3ZFeU5ER1pkZ0t6S21KVnUzVjhfRV9qRGJNb01HNkVUSVNIV0pmdEU4YU9fcGJBWmU0?oc=5","date":"2026-02-16","type":"pipeline","source":"prnewswire.com","summary":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight - prnewswire.com","headline":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQUJTOFNtNXlGV2E2bXR1MDVUbFBwOFRoa00zT3d6VlQzNEprTlBSa2RrVFNkeExGQjB6UUUxQXZBMFYzTGZONFRDTWI0dV9QTV81ZDRoVy1lX1VUOU1VMi1TcWlBWTA4SDc1SkRsSTRBdFQ5WnBWTmxYZWU4eXprTU9mMUpzV21ueF9kNjBZWkhhcTBWUTg2VUluTnZ0aHVzWTlBMmc3NjdwQQ?oc=5","date":"2025-12-17","type":"pipeline","source":"The Business Journals","summary":"Annapolis firm raises $25M for tree-based skin disease treatment - The Business Journals","headline":"Annapolis firm raises $25M for tree-based skin disease treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxORUJaV3N2MjhudlBHRzhtZHpHMnpza2NRdG5kaDMwV1kyakFTOHpHamsyQXJnMjU0alphRGRMR0w5YUxXQUQ0ZTFiQ3VGaEJnV20tLUpyUHNGYkZ3eDY5aDFFUWVYT3BHUkRfSVlnSTd2dFByMm1zTnd3amRpaFJvWENsZ0RwYThUYmQ2eXk1dUVHdHZXaDNraTBZUFZUN0hlZFFraG8tOUlDQlFudkZ2Z3ZCUnh4QWJ4VzlVbTA4T0ladTRkSGtLd0lOc2dhWUtjWnlFcFp6RjJMMXlnVmc?oc=5","date":"2025-12-12","type":"pipeline","source":"prnewswire.com","summary":"Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline - prnewswire.com","headline":"Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQdEFnQktFM210eXdiZmRhVlE4Y3FUTndfak5Cell5OFgyR1Z1QWxsaks4TzU0NTBvZlJIc0o3enpwWTlTYXBFR3o4eFZNZUg2QUpEZGN5Z3ZsTFRqTmZOMVBSZVpoa1YxT3ZHbFlaVVJOZHBWZjFkSE1jSFpXSVVpYVl2U1VhSHRJS1daVHZkSHAtLW5nbW1aeWZIZk9CQUxLNnVlYVF6VVZNRVdtT3ZpVzhMVkI1ODFPLUpqLWpBU3dEVnpWSldBX1JaTmZaX1VTUFJEc0hubWtXZGVwWmw4UmlyLUpTbk5MYVhCRENwaVByRVhzZXhobF9wUGJNYzUtMGNzWEFqbkN3enFKdFplVjJnYzVPQVduMDAzZ1Jn?oc=5","date":"2025-12-08","type":"regulatory","source":"GlobeNewswire","summary":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma - GlobeNewswire","headline":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPZ2Y5bllab2FzTHJwVDhqTDVnWHVNWVpueFFhOXFKR1JSTEhhOEFFY3JhbkxWYjF1aG9OZnEydVJRX0x1SkhBei1vUEhaNnlfM2NEVEFTSUFKSDhZMFZwV19yN0VnNDdsVEp4akxVcFJoeWJYQ2t6dFBiQ05ocnBONVpnYnRiNkNLRWJJMnBDNHpyQklyaU4zY0k1X1pSVzU1TFp5bGpWY0prcko3VlE?oc=5","date":"2025-12-04","type":"pipeline","source":"The Business Journals","summary":"Cincinnati drug firm lands $25M in largest-ever Queen City Angels-led investment round - The Business Journals","headline":"Cincinnati drug firm lands $25M in largest-ever Queen City Angels-led investment round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPUXV0b09nekJtTjJ1eThWV0RCd094UU5RWlRsbG80TlpEd3RqRGN6MWtxdG15S3ZJLVd3V2JmbFM1M3dWVV83WlkzM28zUnhSYmFIQVEyQWNQRUdXeDRMOHZjZEtGR0cxcDI1R2drT0tYWGVoYXI3S29uejY1TFI2VW9rMjdkRWx3MDc5OUhFdFlaOENvNllsR0ZmakJqRVVBUGlhT1dtWTU5a1o1b3ZVWTNoUmJvcHRmOGtrVmpsUF9kS2JGck1NcXhTVnRKNzNlT29V?oc=5","date":"2025-10-27","type":"patent","source":"prnewswire.com","summary":"Alphyn Expands Patent Estate with New U.S. Patent for Atopic Dermatitis Therapeutic - prnewswire.com","headline":"Alphyn Expands Patent Estate with New U.S. Patent for Atopic Dermatitis Therapeutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxObTlGNnRRaWIyeE02R2FCNG1QVHV3aGFFc2UtSGhnZWJiS3J0OVZzSzRPLTFFQXFDaVpSazRzM0VmWVhYYi0tUkZTTzVJTE9XYkFtT2pJRS1qckVDNFVmSGllMEVuem81S012VEtvcW9VVmNjenFWS1pQY2VSVHdxU2t1R001YU1WZVVBakNzYzU1RjBYT1BSZFRVNVprdWJLaVU2QU91Q00yNGg0ZEh2ejMtMjhHeVZrQnVTNUU4cDdKY1ZfWXBxT3VJN0J1OWVkQTgwemZMS042QlNsY0MwbmVNYTQwZFdBVjcxYQ?oc=5","date":"2025-02-19","type":"regulatory","source":"prnewswire.com","summary":"Alphyn Secures FDA Clearance of Investigational New Drug Application for Atopic Dermatitis Treatment - prnewswire.com","headline":"Alphyn Secures FDA Clearance of Investigational New Drug Application for Atopic Dermatitis Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNYi05QmdYVUJ3akthWnJ4UFF5eFl0cnFPUjdMblNKQjBiTXl5T1g2bk9wZ0VNRG9IMzNOMlAyVzZIQjhfTGYwcXVINzJjUUMzYnRoR0ZWT2lMY21RN2NPZ2hLZE1FZDYtZ1dwekRhNk9CMXJwZWdJdm9OaWU1V0dtdkYxdUF0Y3lMVUYyVHladm0?oc=5","date":"2022-12-05","type":"pipeline","source":"Yahoo Finance","summary":"Atopic Dermatitis Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Yahoo Finance","headline":"Atopic Dermatitis Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOdHc3SERqMzNfSGR2STR2eDhITnRJSkhCY3M2QkZBdWlsdk0zSF9neE5GVG9Rd0hDQkZUWW5Cd2V5UWZ0d180TXFsbnNsYkx2ZFRQUlY0TFdDOXdJNXBSbDNZNmJSNHBWMUJLNEl0LVlCRTI4a1B2TDJLTDZDN2hjT2Yxa0NKSEw2S0RzWTZHazhGTzBHZVV2a1ZQWVE5NklDQllDTl9pSk1nT0ZhRkgxWm80czE2NVdtTU1EWDFDNllHQm44?oc=5","date":"2022-09-16","type":"pipeline","source":"The Business Journals","summary":"Queen City Angels leads Alphyn Biologics' $3.3M Series A - The Business Journals","headline":"Queen City Angels leads Alphyn Biologics' $3.3M Series A","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}